Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 3 189 4043 186 2313 105 3952 789 926--
Entreprise Value (EV)1 2 844 1562 875 1572 777 5452 345 9392 233 4182 094 357
P/E ratio 19,9x14,4x16,0x14,7x12,0x11,5x
Yield 2,23%2,29%-2,80%3,06%3,30%
Capitalization / Revenue 2,45x2,44x2,39x2,19x2,08x2,03x
EV / Revenue 2,19x2,20x2,14x1,84x1,67x1,52x
EV / EBITDA 10,2x9,35x8,95x7,71x6,16x5,62x
Price to Book 2,51x2,49x2,41x2,02x1,83x1,69x
Nbr of stocks (in thousands) 1 976 0871 921 1521 858 4051 857 474--
Reference price (JPY) 1 6141 6591 6711 5021 5021 502
Last update 04/26/201804/25/201905/14/202011/02/202011/02/202011/02/2020
1 JPY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 1 300 3161 306 3481 300 8431 271 6351 341 3031 377 136
EBITDA1 278 121307 370310 387304 466362 326372 534
Operating profit (EBIT)1 213 258243 912243 991238 206285 274291 474
Operating Margin 16,4%18,7%18,8%18,7%21,3%21,2%
Pre-Tax Profit (EBT)1 218 113248 967245 350236 776287 350293 831
Net income1 164 679222 265195 411189 641229 415234 576
Net margin 12,7%17,0%15,0%14,9%17,1%17,0%
EPS2 81,1115104102125131
Dividend per Share2 36,038,0-42,146,049,6
Last update 04/26/201804/25/201905/14/202012/02/202012/02/202011/15/2020
1 JPY in Million
2 JPY
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 345 248311 074327 850443 987556 508695 569
Leverage (Debt / EBITDA) -1,24x-1,01x-1,06x-1,46x-1,54x-1,87x
Free Cash Flow1 190 815233 440-167 795230 153226 803228 522
ROE (Net Profit / Equities) 13,0%17,6%15,3%14,4%16,3%15,6%
Shareholders' equity1 1 266 7621 262 8691 277 1961 318 8361 405 1891 502 007
ROA (Net Profit / Asset) 11,9%13,3%11,6%9,47%10,2%9,70%
Assets1 1 388 8931 676 5161 678 8582 003 2542 249 1642 418 309
Book Value Per Share2 642667694742822889
Cash Flow per Share2 113148140136146141
Capex1 25 07725 19041 26740 75040 50040 000
Capex / Sales 1,93%1,93%3,17%3,20%3,02%2,90%
Last update 04/26/201804/25/201905/14/202012/02/202012/02/202011/02/2020
1 JPY in Million
2 JPY
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (JPY)
2 789 925 809 816
Capitalization (USD)
26 685 597 140
Net sales (JPY)
1 300 843 000 000
Net sales (USD)
12 456 872 568
Number of employees
15 883
Sales / Employee (JPY)
81 901 593
Sales / Employee (USD)
784 290
Free-Float
99,2%
Free-Float capitalization (JPY)
2 767 299 992 791
Free-Float capitalization (USD)
26 469 181 551
Avg. Exchange 20 sessions (JPY)
10 621 232 286
Avg. Exchange 20 sessions (USD)
101 708 920
Average Daily Capital Traded
0,4%
EPS & Dividend